newsdog Facebook

China Digest: Medbanks nabs $59m Series D; Shenzhen Lihexing snags $19m

Deal Street Asia 2019-01-11 14:52:59

China Digest: Medbanks nabs $59m Series D; Shenzhen Lihexing snags $19m

T-lymphocytes attack a migrating cancer cell. Visual from Medisix's website.


China’s oncology database firm Medbanks Network Technology has raised $59 million in a Series D round while Shenzhen Lihexing has secured a funding of nearly $19 million.

Medbanks completes $59m Series D

an oncology database firm, has secured 400 million yuan ($59 million) in a Series D financing round led by and , China Money Network reported.

Other investors in this round include IDG Capital and existing investors Tencent, Eight Roads Ventures China and its sister fund F-Prime Capital Partners. Established in 2014, Medbanks has developed a multi-data service platform for oncologists and cancer centers in China. The fresh proceeds will be used to expand its clinical network and improve its database system.

Shenzhen Lihexing snaps $19m funding

, a Chinese supplier of industrial automation equipment, has raised 128 million yuan ($18.86 million) in the latest financing round led by Shenzhen Capital Fortune Investment Management.

The round saw participation from Chinese investment house , CMN reported.

Shenzhen Lihexing manufactures flexible industrial automation equipment such as smart phone testing equipment and automated packaging equipment. It has served over 470 companies including Huawei, Foxconn, Nokia, Microsoft, Canon and Fuji.



 

 

 

 

Subscribe to our newsletter.

Bring stories like this into your inbox every day. Sign up for our newsletter — The Daily Brief.